IOCB Tech Group
IOCB Tech donates 7 million CZK to fight coronavirus
IOCB Tech has donated 7 million Czech crowns (250 thousand euros) for research and development of new diagnostic tests for the infectious disease COVID-19.
SHINE and IOCB deliver Lu-177 dose to GE Healthcare
SHINE Medical Technologies LLC, IOCB Prague, and GE Healthcare today announced the production of patient dose quantities of the therapeutic isotope lutetium-177 (Lu-177).
UCT and IOCB Prague establish special research chair
A prestigious new position is being established for a leading foreign expert in drug discovery and development at UCT Prague in collaboration with IOCB Prague.
Prague-Weizmann Summer School on Drug Discovery 2019
We are proud to announce that IOCB Tech is a co-organizer of the 6th year of the Prague-Weizmann Summer School on Drug Discovery 2019.
SHINE and IOCB enter Lu-177 process license agreement
SHINE Medical Technologies, Inc. and IOCB Prague have entered into an intellectual property license agreement providing SHINE with a global, exclusive license to a novel method for separating rare earth elements.
Prague-Weizmann Winter School In Drug Discovery
Following four successful years of the Prague Summer School on Advances in Drug Discovery, this year the school will be held jointly with the Weizmann Institute of Science in Rehovot, Israel.
IOCB Tech at BioInternational in Boston
IOCB Tech will be at the 25th anniversary of BioInternational in Boston. We are part of the BioMedChemCluster and can be found at Booth 1908a.
IOCB Tech at BioVaria 2018
IOCB Tech is again one of the partners at the BioVaria conference. The event will take place April 23-24, 2018, in Munich, Germany.
Three featured projects with self-explanatory videos. Please follow the link and like always if you would like to learn more about the projects and/or IOCB-TTO please don’t hesitate to contact us via email or phone.